# The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)

> **NCT07190534** · — · NOT_YET_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Frontal Fibrosing Alopecia
- Cicatricial Alopecia

## Interventions

- **DRUG:** Hydroxychloroquine (HCQ)
- **DRUG:** Methotrexate (MTX)

## Key facts

- **NCT ID:** NCT07190534
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2026-11
- **Final completion:** 2027-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190534, "The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07190534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*